key: cord-0801789-oxr86eu9
authors: Shamsoddin, Erfan
title: Saliva: a diagnostic option and a transmission route for 2019-nCoV
date: 2020-06-26
journal: Evid Based Dent
DOI: 10.1038/s41432-020-0104-8
sha: 1e8b426c2ce7b3dff9792f009947ba22311dc255
doc_id: 801789
cord_uid: oxr86eu9

Data sources This review included 13 clinical studies (observational or clinical trial) which reported results of studies of the 2019 novel coronavirus (2019-nCoV). The other 62 referenced papers were of different types (eg, reviews, WHO protocols, letter to editor etc). Study selection The study selected trials, reviews, and in-vitro research assessing the critical aspects of saliva as an easily accessible and early-stage diagnostic source, and also an entry route for 2019-nCoV. Most of the clinical studies were descriptive case series of patients who had contracted 2019-nCoV in China. These were mainly studies designed to compare saliva samples with throat swabs, with regard to the presence of 2019-nCoV RNA. Another aspect of the included studies was the susceptibility of oral tissues to 2019-nCoV due to the expression of angiotensin-converting enzyme II (ACE2) as a receptor for the 2019-nCoV. Some review studies and clinical infection control protocols were also included to discuss the transmission patterns of 2019-nCoV from the oral cavity. Studies were not restricted to English language and they were not all full-text papers. Data extraction and synthesis A narrative synthesis of the results was conducted using distinct headings and subheadings, defined by the authors based on relevancy to the consensus about the importance of saliva with reference to 2019-nCoV. Results There was an inherent heterogeneity among the included clinical studies concerning their designs, sampling techniques, and the results about the diagnostic value of saliva. The percentage of coronavirus disease of 2019 (COVID-19) patients with positive 2019-nCoV RNA varied from 12.9% to 91.67% among these studies. Regarding the possibility of direct virus invasion into the oral tissues, the results suggested that ACE2+ cells in salivary glands could possibly be the target cells of 2019-nCoV and theoretically could generate infectious saliva in a sustained way. Furin was suggested as another protein which makes the tongue more vulnerable to 2019-nCoV, especially in conditions inducing its upregulation (for example, squamous cell carcinoma). According to the comparisons between 2019-nCoV and SARS-CoV, saliva could be considered of diagnostic value via the early detection of viral RNA for both of the viruses. Whilst the viral peak was shown to be at onset of symptoms for 2019-nCoV, it can linger up to the tenth day after the appearance of symptoms for SARS-CoV. Finally, this paper warns about airborne transmission, particularly for close contacts. Conclusions Saliva can be proposed as an easily accessible diagnostic source although further clinical studies are required. Given the presence of viral RNA in saliva in the early stages of COVID-19, the recommendations to wear masks to prevent the rapid transmission of infectious droplets into the air, and keep a safe distance from other people are clearly based in evidence.

is currently a multi-stage process in which epidemiological, clinical, and paraclinical evidence (for example, laboratory and radiographic tests) should be assessed simultaneously in order to reach a definite answer. Fig. 1 illustrates the concepts underpinning this process.

Proposing new diagnostic measures can be of critical importance. This paper suggests that saliva is a convenient, accessible, and cost-efficient option. The literature supports the view that saliva can give diagnostic benefits. 3 The authors present a summary of the most critical studies in an appealing, organised way. However, the specific purpose of this paper is difficult to identify explicitly, and the sources and methods of the citation search were not clearly described. In addition, no details were provided about the inclusion and exclusion criteria of the selected papers within this research and another missing step was the methodology for the validity assessment of the reviewed material. Although the authors of the study did present the data in a systematic manner, there was no weighting or pooling of the results. This can be partly explained given that the literature about Saliva: a diagnostic option and a transmission route for 2019-nCoV

Practice points

• Noticing the diagnostic value of saliva for COVID-19 at early stages, its collection (and especially self-collection) could be beneficial for patients. • Wearing a mask, keeping a safe distance from others, and sticking to the infection control protocols for dental practice environments should be taken more seriously given that dentists are at high risk. Accordingly, effective disinfection and ventilation of dental offices is thought to be vital for all the oral healthcare providers.

Facing new challenges for specialties who do not usually consider themselves at high risk of serious or fatal disease is extremely difficult. For dental practitioners who are believed to be at great risk of transmission for infectious airborne diseases via persistent exposures to aerosols and possible infectious droplets in their environments the current crisis is very threatening. At present, following the infection control guidelines, and using personal protective equipment is vitally important, and all that can be confidently recommended for dental practitioners and dental healthcare workers. 4 

Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine

Guidelines for infection control in dental health-care settings -2003

Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis

Transmission routes of 2019-nCoV and controls in dental practice